国产精品亚洲LV粉色,在电梯伦流澡到高潮H男男,久久久亚洲一区二区三区,国色天香A区与B区

扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  人才招聘  关于我们  联系我们
午夜爽喷水无码成人18禁三级,国模无码视频一区二区三区,中文字幕被公侵犯的漂亮人妻
首页 > 产品中心 > 一抗 > 产品信息
Mouse Anti-TBP  antibody (bsm-33227M)
订购热线:400-901-9800
订购邮箱:sales@www.hhi8.com
订购QQ:  400-901-9800
技术支持:techsupport@www.hhi8.com
说明书: 50ul  100ul  200ug
50ul/1180.00元
100ul/1980.00元
200ug/5600.00元
大包装/询价

产品编号 bsm-33227M
英文名称 Mouse Anti-TBP  antibody
中文名称 TATA结合蛋白单克隆抗体
别    名 TBP_HUMAN; TATA-box-binding protein; TATA-box binding protein; GTF2D1; TF2D; TFIID; TATA sequence-binding protein; TATA-binding factor; TATA-box factor; Transcription initiation factor TFIID TBP subunit; HDL4; TBP1; GTF2D; SCA17;  
产品类型 内参抗体 
研究领域 细胞生物  神经生物学  干细胞  转录调节因子  表观遗传学  
抗体来源 Mouse
克隆类型 Monoclonal
克 隆 号 6G8
交叉反应 Human,Rat (predicted: Mouse)
产品应用 WB=1:500-1000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100,IF=1:100-500
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理论分子量 38kDa
细胞定位 细胞核 
性    状 Liquid
浓    度 1mg/ml
免 疫 原 Recombinant human TBP protein 
亚    型 IgG
纯化方法 affinity purified by Protein G
缓 冲 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存条件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事项 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
产品介绍 Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes TBP, the TATA-binding protein. A distinctive feature of TBP is a long string of glutamines in the N-terminus. This region of the protein modulates the DNA binding activity of the C terminus, and modulation of DNA binding affects the rate of transcription complex formation and initiation of transcription. The number of CAG repeats encoding the polyglutamine tract is usually 25-42, and expansion of the number of repeats to 45-66 increases the length of the polyglutamine string and is associated with spinocerebellar ataxia 17, a neurodegenerative disorder classified as a polyglutamine disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2016]

Function:
General transcription factor that functions at the core of the DNA-binding multiprotein factor TFIID. Binding of TFIID to the TATA box is the initial transcriptional step of the pre-initiation complex (PIC), playing a role in the activation of eukaryotic genes transcribed by RNA polymerase II. Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (preinitiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1 with the rDNA promoter. SL1 is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA.

Subunit:
Binds DNA as monomer. Belongs to the TFIID complex together with the TBP-associated factors (TAFs). Component of the transcription factor SL1/TIF-IB complex, composed of TBP and at least TAF1A, TAF1B TAF1C and TAF1D. Association of TBP to form either TFIID or SL1/TIF-IB appears to be mutually exclusive. Interacts with TAF1A, TAF1B and TAF1C. Interacts with TFIIB, NCOA6, DRAP1, DR1 and ELF3. Interacts with SPIB, SNAPC1, SNAPC2 and SNAPC4. Interacts with UTF1. Interacts with BRF2. Interacts with UBTF. Interacts with GPBP1. Interacts with CITED2 (By similarity). Interacts with ATF7IP. Interacts with HIV-1 Tat.

Subcellular Location:
Nucleus.

Tissue Specificity:
Widely expressed, with levels highest in the testis and ovary.

DISEASE:
Defects in TBP are the cause of spinocerebellar ataxia type 17 (SCA17) [MIM:607136]. Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA17 is an autosomal dominant cerebellar ataxia (ADCA) characterized by widespread cerebral and cerebellar atrophy, dementia and extrapyramidal signs. The molecular defect in SCA17 is the expansion of a CAG repeat in the coding region of TBP. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.

Similarity:
Belongs to the TBP family.

SWISS:
P20226

Gene ID:
6908

Database links:

Entrez Gene: 6908 Human

Entrez Gene: 21374 Mouse

Entrez Gene: 117526 Rat

Entrez Gene: 395995 Chicken

Omim: 600075 Human

SwissProt: O13270 Chicken

SwissProt: P20226 Human

SwissProt: P29037 Mouse

Unigene: 1100 Human

Unigene: 590872 Human

Unigene: 244820 Mouse

Unigene: 22712 Rat



产品图片
Sample: U87MG(Human) Cell Lysate at 30 ug Primary: Anti- TBP (bsm-33227M) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Mouse IgG at 1/20000 dilution Predicted band size: 38 kD Observed band size: 40 kD
Paraformaldehyde-fixed, paraffin embedded (rat testis tissue); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (TATA binding protein) Monoclonal Antibody, Unconjugated (bsm-33227M) at 1:400 overnight at 4°C, followed by operating according to SP Kit(Mouse)(sp-0024) instructionsand DAB staining.
版权所有 2004-2026 www.www.hhi8.com 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    证书编号: 00124Q34771R2M/1100
通过国际医疗器械-质量管理体系ISO 13485:2016 GB/T 42061-2022    证书编号: CQC24QY10047R0M/1100
京ICP备05066980号-1         京公网安备110107000727号